Related Experiment Videos
Drug-induced interstitial lung disease
1Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Current Opinion in Pulmonary Medicine
|September 1, 1996
Summary
Drug-induced lung injury can affect various respiratory structures and often mimics other interstitial lung diseases. Early recognition and drug cessation are crucial for patient survival, as this condition is diagnosed by exclusion.
Area of Science:
- Pulmonology
- Pharmacology
- Toxicology
Background:
- Medications can cause a wide spectrum of adverse pulmonary effects.
- Drug-induced lung disease often presents with symptoms similar to other interstitial lung diseases.
- Diagnosis typically relies on excluding other causes.
Purpose of the Study:
- To highlight the diverse adverse pulmonary effects of drugs.
- To emphasize the importance of recognizing drug-induced lung disease.
- To stress the need for prompt drug discontinuation.
Main Methods:
- Review of potential drug-induced lung pathologies.
- Discussion of diagnostic challenges, including mimicry of other interstitial lung diseases.
- Emphasis on clinical diagnosis by exclusion.
Main Results:
- Drugs can adversely affect lungs, airways, pleura, mediastinum, and interstitium.
- Drug-induced interstitial lung disease appearance can mimic other conditions.
- Delayed recognition and management can lead to fatal outcomes.
Conclusions:
- Awareness of drug-induced lung injury is critical for timely diagnosis.
- Prompt drug withdrawal is essential for improving patient prognosis.
- Drug-induced lung disease requires a high index of suspicion and exclusion of other causes.